{
    "id": "dbpedia_8437_1",
    "rank": 52,
    "data": {
        "url": "https://globalhealth.unc.edu/malawi/research/studies/",
        "read_more_link": "",
        "language": "en",
        "title": "UNC Project-Malawi",
        "top_image": "https://globalhealth.unc.edu/malawi/wp-content/themes/heelium-white-coat/assets/favicons/favicon-32x32.png",
        "meta_img": "https://globalhealth.unc.edu/malawi/wp-content/themes/heelium-white-coat/assets/favicons/favicon-32x32.png",
        "images": [
            "https://globalhealth.unc.edu/malawi/wp-content/uploads/sites/714/2024/08/ProjectMalawi_logo_2c_CarolinaBlueBlack_rgb-1.png",
            "https://globalhealth.unc.edu/malawi/wp-content/uploads/sites/714/2023/03/Institute-for-Global-Health-and-Infectious-Diseases_logo_white_v.png",
            "https://globalhealth.unc.edu/malawi/wp-content/themes/heelium-white-coat/images/SchoolMedicine_logo_white.svg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "https://globalhealth.unc.edu/malawi/wp-content/themes/heelium-white-coat/assets/favicons/apple-touch-icon.png",
        "meta_site_name": "",
        "canonical_link": "https://globalhealth.unc.edu/malawi/research/studies/",
        "text": "Current studies\n\nACTG A5354\n\nEffect of Antiretroviral Treatment Initiated during Acute HIV-1 Infection on measures of HIV-1 Persistence and on HIV-1- Specific Immune Responses\n\nProf. Mina Hosseinipour\n\nACTG 5362\n\nPhase IIc Trial of Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis\n\nDr. Cecilia Kanyama\n\nACTG 5381\n\nObservational Cohort to Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of Tenofovir-Lamivudine-Dolutegravir (TLD) for First- or Second-Line ART or with Rifampicin-Containing TB Treatment\n\nDr. Cecilia Kanyama\n\nCIPHER-EID\n\nFeasibility pilot to characterize a differentiated service delivery model for hiv early infant diagnosis in high-risk mother-infant pairs\n\nDr. Maganizo Chagomerana\n\nCoVPN 3008\n\nA randomized efficacy study of a COVID-19 mRNA 2-dose Vaccine in African regions with SARS-CoV-2 variants of concern.\n\nProf. Mina Hosseinipour, Dr. Friday Saidi\n\nENHANCE-CBR\n\nEnhancing post-acute mental health outcomes for patients with psychosis in Malawi through nurse-delivered community-based rehabilitation:\n\nDr. Sarah Rustein\n\nEMPIRICAL\n\nA multicenter, open-label randomized controlled clinical trial for treatment against cytomegalovirus and tuberculosis in HIV infected infants with severe pneumonia\n\nDr. Tisungane Mvalo\n\nHPTN 084 open label extension\n\nA Phase 3 Double Blind Safety and Efficacy Study of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women\n\nProf. Mina Hosseinipour\n\nIMPAACT P1115\n\nPharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs during Pregnancy and Postpartum\n\nDr. Lameck Chinula\n\nIMPAACT 2016\n\nEvaluation of a group based intervention to improve mental health and ART adherence among youth living with HIV in low resource setting\n\nDr. Lameck Chinula\n\nIMPAACT 2026\n\nPharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs during Pregnancy and Postpartum\n\nDr. Lameck Chinula\n\nIMPAACT 2028\n\nIt is a multisite observational study of long-Term Clinical, Immunologic, and Virologic Profiles of Children who Received Early Treatment for HIV\n\nDr. Lameck Chinula\n\nAMP ATI\n\n(HVTN 805/HPTN 093)\n\nAn Antiretroviral analytical treatment interruption study (ATI)\n\nProf. Mina Hosseinipour\n\nSAVI\n\nGlobal sequence and surface antigenic diversity of Treponema pallidum outer membrane proteins\n\nProf. Irving Hoffman, Dr. Mitch Matoga\n\nAMC 100\n\nA Phase II Multicenter Study of Pomalidomide Monotherapy in HIV-Positive Individuals With Kaposi Sarcoma (KS) in Sub-Saharan Africa (SSA)\n\nDr. Lusayo Simwinga\n\nAMC 099\n\nA Randomized, Placebo-Controlled Trial of HPV Vaccination to Reduce Cervical High-Grade Squamous Intraepithelial Lesions among HIV-Infected Women Participating in an HPV Test-and-Treat Program (COVENANT)\n\nDr. Lameck Chinula\n\nLCCC 1905\n\nA novel cervical cancer screen-and-treat demonstration project with HPV self-testing and thermocoagulation for women in Lilongwe, Malawi\n\nLCCC 1940\n\nIsothermal Acid Amplification System Device\n\nLCCC 1950\n\nRituxmab for multicentric Castleman disease in Malawi, a single-arm phase ii safety/ efficacy trial\n\nUNCPM 21410\n\nOption B+ ART Safety and Durability during first and subsequent pregnancies\n\nProf. Mina Hosseinipour\n\nHost Directed Immune Modulatory therapy in cryptococcal meningitis (HIT-CRYPTO)\n\nDr. Cecilia Kanyama\n\nA prospective cohort evaluating the pregnancy rates and pharmacokinetic interactions among HIV-infected Malawians on Efavires or Dolutegravir initiating the Levonorgestrel Implant or the Depot Medroxyprogestetrone Acetate Injectable\n\nDr. Jennifer Tang\n\nUptake of voluntary medical male circumcision among men attending a sexually transmitted infections clinic Lilongwe, Malawi\n\nDr. Mitch Matoga\n\nUNCPM 22201 HIV Engagement and Adolescent Depression Support\n\nProf. Bradley Gaynes\n\nLCCC 1229\n\nDeveloping a Prospective Lymphoma Clinical Cohort in Malawi\n\nProf. Yuri Fedoriw\n\nUNCPM 21918 Perspectives on the provision of abortion and post-abortion care in Malawi: A Qualitative Study\n\nDr. Friday Saidi\n\nSecondary Analysis of STI Clinic Data at Bwaila Hospital, Malawi\n\nDr. Mitch Matoga\n\nA5384\n\nA Phase II Randomized, Open-Label Trial of a Six-Month Regimen of High-dose Rifampicin, High-dose Isoniazid, Linezolid, and Pyrazinamide versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents with Tuberculous Meningitis: Improved Management with Antimicrobial AGents Isoniazid rifampiciN LinEzolid for TBM (IMAGINE-TBM).\n\nDr. Cecelia Kanyama\n\nHVTN 405/HPTN 1901\n\nCharacterizing SARS-CoV-2-specific immunity in convalescent individuals\n\nDr. Melda Phiri\n\nAMC-104\n\nFeasibility study of ocular surface squamous neoplasia (OSSN) surgical excision in people living with HIV in sub-Saharan Africa (SSA)\n\nDr. Amos Nyaka\n\nUnderstanding Engagement to HIV Prevention and Sexual and Reproductive Health Services among Women after Participating in an HIV Vaccine Trial\n\nDr. Mitch Matoga\n\nIGHID 11904: Global sequence and surface antigenic diversity of Treponema pallidum outer membrane proteins\n\nDr. Mitch Matoga\n\nIGHID 12057 Barriers and Facilitators of Syphilis Vaccine Trial Participation\n\nDr. Mitch Matoga\n\nIGHID 12140 Genomic epidemiology of Treponema pallidum strains infecting women and men in low- and middle-income countries to inform syphilis vaccine development\n\nDr. Mitch Matoga\n\nIGHID 12235 PRomoting Equity for Pregnant Adolescents in HIV REsearch (PREPARE) in Malawi, Botswana, South Africa, and the USA\n\nDr. Agatha Bula\n\nLCCC 1905 – A Novel Cervical Cancer Screen-and-Treat Demonstration Project with HPV Self-testing and Thermocoagulation for women in Lilongwe, Malawi\n\nDr. Lameck Chinula\n\nLCCC 2127\n\nA prospective observational clinical cohort study to assess the safety and efficacy of standard of care risk-adjusted pediatric Burkitt lymphoma treatment incorporating high-dose Methotrexate in Malawi.\n\nDr. Kate Westmoreland\n\nLCCC 2122 – Women’s perceptions and attitudes towards mobile phone text messaging as a model of communication to receive HPV results and remind women to report for cervical cancer treatment in Lilongwe, Malawi.\n\nJohn Chapola\n\nLCCC 2147 – Implementing a Breast Cancer Screening/Early Detection Intervention for Cervical Cancer Screening Providers in Malawi\n\nDr. Tamiwe Tomoka\n\nLCCC 2151: Validation and administration of a new tablet-based voice-enabled application to measure patient-reported outcomes (PROs) among low-literacy pediatric and adolescent hematology-oncology patients in Malawi\n\nDr. Kate Westmoreland\n\nUNCPM-22301-Using Implementation Science to Accelerate a Path to Scale for Injectable PrEP in Malawi. An implementation Phase.\n\nDr. Agatha Bula\n\nUNCPM 22212\n\nEnhanced detection of treatable infections in Malawian children under five years with complicated severe acute malnutrition\n\nDr. Tisungane Mvalo and Dr. Bryan Vonasek\n\nUNCPM 22210\n\nAn international repeated cross-sectional observational study of blood donation in Sub-Saharan Africa\n\nDr. Maganizo Chagomerana\n\nUNCPM 22209\n\nEnhancing post-acute mental health outcomes for patients with psychosis in Malawi through nurse-delivered community-based rehabilitation: The ENHANCE Pilot\n\nDr. Brian Pence\n\nUNCPM 22206: Evaluating the Risk and Impact of Aspiration in Breastfed Infants with Severe Pneumonia in Malawi\\\n\nDr. Nadia Hoeskra\n\nUNCPM 22201 – HIV Engagement and Adolescent Depression Support\n\nProf. Bradley Gaynes\n\nUNCPM 22118 – Treatment outcomes following thermal ablation treatment among HIV+ and HIV- women in Malawi\n\nDr. Chemtai Mungo\n\nUNCPM 22115: Integrating Enhanced HIV Pre-exposure Prophylaxis into a Sexually Trasmitted Infection Clinic in Lilongwe\n\nDr. Sarah Rustein\n\nUNCPM 22113: Impact of Parasistic Infections on Intestinal Epithelial Barrier and Immune Activation among Persons Living with HIV in Lilongwe-Malawi\n\nDr. Melissa Reimer-McAtee\n\nUNCPM 22109: Evaluation of Rituximab on Malaria-specific Immunological Profile and Subsequent Risk of Malaria among DLBCL Patients in a Malaria Endemic Region\n\nDr. Matthews Painschab\n\nUNCPM 22106: Erythrocyte Alloimmunization Among Transfused Children with Sickle Cell Anemia in Malaw\n\nDr. Russell Ware\n\nUNCPM 22102 – Improving case detection of tuberculosis in children with severe acute malnutrition in Malawi"
    }
}